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The people of Indonesia have been afflicted by dengue, a mosquito-borne viral disease,
for over 5 decades. The country is the world’s largest archipelago with diverse
geographic, climatic, and demographic conditions that may impact the dynamics of
disease transmissions. A dengue epidemiology study was launched by us to compare
and understand the dynamics of dengue and other arboviral diseases in three cities
representing western, central, and eastern Indonesia, namely, Batam, Banjarmasin, and
Ambon, respectively. A total of 732 febrile patients were recruited with dengue-like
illness during September 2017–2019 and an analysis of their demographic, clinical,
and virological features was performed. The seasonal patterns of dengue-like illness
were found to be different in the three regions. Among all patients, 271 (37.0%) were
virologically confirmed dengue, while 152 (20.8%) patients were diagnosed with probable
dengue, giving a total number of 423 (57.8%) dengue patients. Patients’ age and clinical
manifestations also differed between cities. Mostly, mild dengue fever was observed in
Batam, while more severe cases were prominent in Ambon.While all dengue virus (DENV)
serotypes were detected, distinct serotypes dominated in different locations: DENV-1
in Batam and Ambon, and DENV-3 in Banjarmasin. We also assessed the diagnostic
features in the study sites, which revealed different patterns of diagnostic agreements,
particularly in Ambon. To detect the possibility of infection with other arboviruses, further
testing on 461 DENV RT-PCR-negative samples was performed using pan-flavivirus
and -alphavirus RT-PCRs; however, only one chikungunya infection was detected in
Ambon. A diverse dengue epidemiology in western, central, and eastern Indonesia was
observed, which is likely to be influenced by local geographic, climatic, and demographic
conditions, as well as differences in the quality of healthcare providers and facilities. Our
study adds a new understanding on dengue epidemiology in Indonesia.
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INTRODUCTION
Indonesia is the world’s largest archipelagic country of about
18,000 islands spread over 1,904,569 km2, which can be
roughly divided into three regions: western, central, and eastern.
The tropical climate of this country is favorable for the
transmission of mosquito-borne diseases, including dengue and
other arboviral diseases (1). This condition also has the potential
for concurrent infections of multiple pathogens, which may have
severe clinical and epidemiological implications (2). Outbreaks
of dengue virus (DENV) and chikungunya virus (CHIKV) are
common, while Zika virus (ZIKV) infection was reported as
early as 1978 in Central Java and was recently detected in
Sumatra (3–5).
Indonesia is one of the countries with the highest dengue
burden globally (6). In 2016, the national incidence rate
(IR) of dengue disease in Indonesia was 78.9 per 100,000
population, which rose from 50.8 per 100,000 population in
2015 (7). While dengue surveillance data in Indonesia is
now accumulating, data on CHIKV and ZIKV transmission
is very limited. Furthermore, their infection rates tend to be
underestimated in part because of their clinical similarity with
dengue. Misdiagnosis is also common. In addition, given the
large number of cases with an unidentified etiology, there
may be other pathogens in circulation that remain unknown
or undetected.
Dengue is a systemic viral infection caused by DENV with
a global burden of an estimated 50 million infections annually
around the world (8). Dengue cases have been reported in
all 34 provinces of Indonesia, with all four DENV serotypes
(DENV-1,−2,−3, and−4) reported to be circulating in the
country (9). The clinical manifestations of dengue can be
classified based on severity into dengue fever (DF), dengue
FIGURE 1 | Study sites in Batam, Banjarmasin, and Ambon cities with dengue virus (DENV) serotype distribution (shown in pie charts), 2017–2019. Map source:
http://www2.demis.nl/worldmap/mapper.asp.
hemorrhagic fever (DHF), and dengue shock syndrome (DSS)
(10). While dengue severity and transmissibility have been
correlated with viral genetics (11), all four of the serotypes of
DENV can cause severe and fatal disease, although DENV-2
and DENV-3 have been more associated with severe disease
(12, 13).
With the vastness of the archipelago, a wide range of
geographic, climatic, and demographic conditions as well as
inequalities in infrastructure and socioeconomic development
are evident in Indonesia. The western regions of the country
tend to be more densely populated and more developed in
terms of infrastructure, in contrast to the eastern counterparts
(14). Moreover, inequality in the availability of health-related
infrastructure and access to services has become a problem.
Provinces in western regions of Indonesia tend to have higher
overall Public Health Development Index scores compared to
eastern regions (15). Whether the epidemiological characteristics
of dengue and other arboviral diseases are influenced by these
diverse conditions is unknown.
This study aims to determine and compare the clinical,
demographic, and virological features of dengue in different
regions of Indonesia. Three study sites representing the
western, central, and eastern regions of Indonesia were
chosen: Batam in Riau Island province, Banjarmasin in
South Kalimantan province, and Ambon in Maluku province,
respectively (Figure 1). The dengue IRs in these provinces
are dynamic, and continued transmission of dengue is
evident (7). The study also aims to determine dengue
epidemiology in areas with high (Batam and Banjarmasin)
and low (Ambon) dengue IRs, within the same period. Febrile
patients presenting to hospitals with symptoms similar to
dengue were recruited and examined for dengue and other
arboviral infections.
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MATERIALS AND METHODS
Ethical Clearance
The study protocol was reviewed and approved by the Eijkman
Institute Research Ethics Committee (EIREC) with approval No.
113/2017. Written informed consent was obtained from patients
recruited for the study. Consent from parents or legal guardians
were obtained on behalf of minors.
Study Sites and Dengue Incidences
The study participants were all patients presenting dengue-
like symptoms and attending a designated referral hospital
in each city where the study was conducted. Patients were
recruited from Santa Elisabeth Hospital in Batam (the largest
city in Riau Island, 1◦05′N 104◦02′E), Dr. H. M. Ansari Saleh
Hospital in Banjarmasin (the capital city of South Kalimantan,
3◦20′S 114◦35′E), and Dr. M. Haulussy Hospital in Ambon
(the capital city of Maluku, 3◦42′S 128◦10′E) during September
2017–2019. The study period covered two typical dengue peak
seasons in the area. Batam’s rainy season usually occurs from
October to April with an average annual temperature of 26.8◦C,
while Banjarmasin occurs from November to April with an
average annual temperature of 26.7◦C, and Ambon from May
to September each year with an average annual temperature
of 26.5◦C (https://en.climate-data.org). The average humidity
in Batam, Banjarmasin, and Ambon are 81, 80, and 84%,
respectively (www.timeanddate.com). In 2016, the population
of Batam, Banjarmasin, and Ambon were 1,236,399, 675,440,
and 427,934, respectively (Statistics Indonesia, 2016. Available
at www.bps.go.id).
In 2016, dengue IRs in Riau Island, South Kalimantan,
and Maluku provinces were 64.1, 101.1, and 21.2 per 100,000
population, respectively. The data showed an increase from
the previous year, which were 51.4, 91.9, and 4.6 per 100,000
population, respectively (7).
Patient Recruitment, Sample Collection,
and Laboratory Examinations
Sample size for patient recruitment was calculated using the
population prevalence estimation formula with an expected
prevalence of 25%, confidence level of 95%, and precision of 5%.
To obtain sufficient representation, ∼300 patients were required
for Batam and Banjarmasin. For Ambon, due to the relatively
low IR of dengue compared to the other two cities, sample
size calculation was further corrected using the finite population
formula, requiring ∼100 patients. Children and adults between
the age of 1 and 65 years, with fever over 38◦C for <5 days
and symptoms suggestive of dengue disease were recruited by
research teams on each site. Those with clear symptoms of upper
respiratory or gastrointestinal tract infections and unwilling to
participate in this study were excluded. Upon hospital admission,
single 3- to 5-ml blood samples were taken during the acute
phase. Sera were separated by centrifugation and kept frozen until
further processing. The demographics and basic hematology data
(hemoglobin, hematocrit, erythrocyte, platelet, and leucocyte
count) were obtained using standard questionnaire and from
hospital medical records.
Case Definitions
Dengue-like illness was defined as acute fever reported by
the patients (16), and in our study, with additional clinical
assessment on symptoms, which were similar to dengue and the
patients presenting to hospitals during dengue season. Probable
and confirmed dengue was defined based on the WHO-SEARO’s
2011 guidelines (10). Probable dengue are cases of acute fever
accompanied by at least one of the clinical signs of dengue,
such as malaise, arthralgia, rash, and retro-orbital pain, as well
as a single positive result in IgM or IgG (10). These cases were
confirmed for dengue when there was at least one of the following
laboratory results: (1) isolation of dengue virus, (2) detection of
DENV NS1 antigen, (3) detection of DENV genomic sequence
by RT-PCR, and (4) a four-fold increase in IgG or IgM DENV-
specific antibodies (10). The latter was irrelevant for our study as
only single acute samples were collected. Cases were diagnosed
as non-dengue if they tested negative for DENV NS1, RT-PCR,
and IgM.
In terms of severity, patients were classified into dengue fever
(DF) if they reported clinical symptoms of dengue but without
signs of plasma leakage (10). Patients exhibiting signs of plasma
leakage were classified into DHF, which is shown by any of the
following signs: a rise in hematocrit of ≥20% from baseline,
pleural effusion, ascites, or hypoalbuminemia (10). Patients were
categorized into DSS if they showed signs of shock, which
include tachycardia, delayed capillary refill time, cold extremities,
poor peripheral pulse, hypotension, and pulse pressure ≤20
mmHg (10).
DENV NS1 Antigen Detection and
Serological Tests
Collected serum samples were tested for the presence of DENV
NS1 antigen and anti-DENV IgG and IgM antibodies using
Standard Q Dengue Duo (Biosensor, Korea) rapid-tests on
sites, performed in accordance with manufacturer’s instructions.
Patients who tested positive for dengue IgM/IgG with clinical
symptoms of dengue were classified as “probable dengue,”
while patients who tested positive for the dengue NS1 antigen
and/or RT-PCR were categorized as “confirmed dengue” (10). To
assess the diagnostic agreement and accuracy in clinical settings
between study sites, the sensitivities, specificities, and predictive
values of NS1 and IgM/IgG diagnostics were compared with RT-
PCR results as the gold standard. These parameters were also
stratified by age, gender, fever day onset, and serotype to compare
the rapid-tests’ performance in different conditions.
DENV RNA Extraction, RT-PCR Detection
and Serotyping
Serum samples were transported to Eijkman Institute for
Molecular Biology in Jakarta under appropriate cold chain
maintenance for further tests to confirm dengue and/or other
arbovirus infections. Viral RNA was extracted from 200 µl of
sera using MagNA Pure LC Total NA extraction kit (Roche,
Mannheim, Germany) in the MagNA Pure LC 2.0 extraction
system (Roche). DENV nucleic acid detection was performed
using Simplexa R© Dengue qRT-PCR (DiaSorin, Saluggia, Italy)
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to simultaneously detect and serotype DENV as previously
described (17). All samples for all three study sites underwent the
same protocols.
Other Arbovirus Detection
All samples that were negative for DENVNS1 and RT-PCR (N =
461) were subjected to other arbovirus screening using broadly
reactive Alphavirus (18) and Flavivirus (19) group-specific RT-
PCRs. Virus genetic material was amplified on 25 µl of OneStep
RT-PCR kit (Qiagen, Hilden, Germany) reaction, containing
400µM dNTPs, 1µM primers, and 5 µl of template RNA. The
thermal cycling conditions were reverse transcription for 30min
at 50◦C, PCR activation for 15min at 95◦C, followed by 35 cycles
of amplification at 94◦C for 45 s, 50◦C for 1min, and 72◦C for
1min, and final extension at 72◦C for 10min. Reactions were
run on 1% agarose gels, and DNA fragments were excised and
purified using QIAquick gel extraction kit in accordance with
the manufacturer’s instruction (QIAGEN). DNA sequencing was
performed using BigDyeTM Terminator v3.1 cycle sequencing
kit, following the manufacturer’s protocol (Applied Biosystems,
USA) on a 3500XL genetic analyzer (Applied Biosystems,
USA). The resulting DNA sequences were compared to banked
specimens using NCBI BLAST (https://blast.ncbi.nlm.nih.gov/
Blast.cgi).
Statistical Analysis
Categorical data between cities were compared using Pearson’s
Chi-square or Fisher’s exact-tests as appropriate, while age and
hematological data between cities were compared using Kruskal–
Wallis-tests. Regression analyses were performed using binomial
logistic regression of clinically relevant potential covariates such
as age and gender for reported symptoms. The performance of
DENV NS1 and IgG/IgM rapid-tests were evaluated using Z-
tests for proportions. Statistical analysis was performed using
R Studio software (http://www.r-project.org) with a p-value of
<0.05 considered as statistically significant.
RESULTS
Patient Characteristics and Clinical
Features
Of the recruited 732 dengue-like illness patients across three
study sites during the same period, 315 were from Batam, 310
from Banjarmasin, and 107 from Ambon. The median age of
patients in Ambon was significantly younger [9 years old (y.o.),
interquartile range (IQR) = 4–16 y.o.] than those in Batam
(15 y.o, IQR = 6–26 y.o.) and Banjarmasin (16 y.o, IQR =
10–23 y.o.) (p < 0.001). Detailed age distribution is shown in
Figure 2. In terms of gender, moremale patients were observed in
Batam and Ambon with a female-to-male ratio of 1:1.1 and 1:1.5,
respectively. However, no statistically significant differences were
observed between the groups. Equal female-to-male ratio was
observed in Banjarmasin.
To understand the temporal distribution of dengue-like illness
incidence in all study sites, we analyzed hospital admission dates
and correlated them with climatic data. We observed that the
temporal distribution of cases was generally similar between
study sites, except for Ambon. Cases in Batam and Banjarmasin
follow seasonal patterns, which peaked during December–May
each year, while in Ambon, during June–November. In general,
the temporal distribution of dengue-like illness cases in all three
FIGURE 2 | Age distribution of dengue-like illness patients in Batam, Banjarmasin, and Ambon.
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study sites peaked around the occurrence of monsoon season in
each region (Figure 3). Dengue-like illness patients in the three
sites exhibited all dengue clinical spectrum (Table 1). Patients
in Batam tend to report less dengue symptoms compared to
those in Banjarmasin and Ambon. The most reported symptoms
in Banjarmasin were loss of appetite, malaise, and nausea,
FIGURE 3 | Temporal distribution of dengue-like illness incidences in relation with average monthly rainfall in Batam (A), Banjarmasin (B), and Ambon (C).
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TABLE 1 | Clinical symptoms of dengue-like illness patients in Batam, Banjarmasin, and Ambon.
Symptoms Proportion of reported symptoms, N (%)* p-value**
Batam (N = 315) Banjarmasin
(N = 310)
Ambon (N = 107)
Headache 185 (58.9)a 193 (64.8)a 106 (99.1)b <0.001
Retro-orbital Pain 36 (11.5)a 46 (16.3)a 102 (95.3)b <0.001
Myalgia 43 (13.7)a 136 (46.9)b 101 (94.4)c <0.001
Arthralgia 32 (10.2)a 75 (26.4)b 81 (75.7)c <0.001
Nausea 101 (32.2)a 225 (73.5)b 101 (94.4)c <0.001
Loss of appetite 145 (46.2)a 269 (87.6)b 98 (91.6)b <0.001
Rash 23 (7.3)a 84 (29.6)b 50 (46.7)c <0.001
Bleeding*** 7 (2.2)a 117 (38.2)b 16 (15.1)c <0.001
Enlarged liver 0 (0.0)a 19 (6.8)b 10 (9.3)c <0.001
Fluid accumulation 2 (0.6)a 4 (1.4)a 30 (28.0)b <0.001
Stomachache 42 (13.4)a 178 (58.6)b 102 (96.2)c <0.001
Malaise 154 (49.0)a 246 (80.9)b 102 (95.3)c <0.001
Anxiousness 53 (16.9)a 73 (25.4)b 81 (75.7)c <0.001
Drowsiness 68 (21.7)a 64 (21.9)a 66 (62.3)b <0.001
Allergy 18 (5.7)a 1 (0.3)b 0 (0.0) <0.001
*Cells in a row with the same superscript letter are ones whose difference in proportions are not significantly different from each other with a Bonferroni-adjusted p-value threshold
of 0.05.
**Pearson’s Chi-Square-Test.
***Bleeding manifestations include any of the following: petechiae, purpura, ecchymosis, epistaxis, gum bleeding, gastrointestinal bleeding, hemoglobinuria/hematuria,
and hypermenorrhea.
while in Ambon were headache, stomachache, retro-orbital pain,
and malaise. Latent class analysis showed that febrile dengue-
suspected cases in Ambon reported significantly more headache,
myalgia, nausea, loss of appetite, malaise, and stomachache
compared to cases in Banjarmasin and Batam (p< 0.001), though
these classes are not associated with DENV detection and are
more related to site.
Dengue and Other Arbovirus Confirmatory
Diagnoses
To determine whether the dengue-like illness patients were
indeed infected by DENV, we tested the patients’ sera using
DENV NS1 antigen rapid diagnostic-test (RDT) during the first
day of hospital admission. In addition to NS1 antigen detection,
we also conducted real-time RT-PCR-tests to simultaneously
detect and serotype the infecting DENV in patients’ sera.
Both NS1 antigen and nucleic acid detection are considered
as confirmatory dengue diagnosis (10). Among 732 patients,
271 (37.0%) of them were virologically confirmed dengue
(Table 2). The highest percentage of virologically confirmed
dengue patients was observed in Banjarmasin (42.6%) and
was lowest in Ambon (30.8%) (Table 2). In addition to the
virologically confirmed dengue, there were 152 (20.7%) patients
that were categorized as probable dengue based on their positivity
in IgM and/or IgG antibodies (Table 2). Even with all dengue
confirmatory tests, there were still 294 (40.2%) of dengue-like
illness patients that remained negative (Table 2).
RT-PCR was used to determine the serotypes of infecting
DENV.While all four serotypes can be detected, distinct serotype
predominance was observed; DENV-1 and−2 in Batam, DENV-3
in Banjarmasin, and DENV-1 in Ambon (Figure 1 and Table 2).
However, a fluctuation of serotype predominance pattern was
found, particularly in Batam, in which DENV-2 prevalence in late
2017 to 2018 was followed by DENV-4 predominance in 2019
(Supplementary Figure 1). We also detected mixed infections
among the patients in Banjarmasin (four patients infected with
DENV-1 and DENV-3, and one patient infected with DENV-1
and DENV-4) and Ambon (one patient infected with DENV-1
and DENV-3). On the whole, the predominant DENV serotypes
circulating in Indonesia during the study was DENV-1 (33.6%),
followed by DENV-3 (28.4%), DENV-2 (20.5%), and DENV-
4 (14.9%).
A subset of samples with DENV NS1- and RT-PCR-negative
results (N = 461, 63.0%) were also subjected to a second round
of RT-PCRs to detect possible infection with other arboviruses.
The pan-flavivirus RT-PCR was positive for 20 samples in this
subset, with DNA sequencing of PCR amplicons confirming
DENV (Table 2). These DENV-positive samples were serotyped
as seven DENV-2 and one DENV-4 in Batam; three DENV-
2, five DENV-3, and one DENV-4 in Banjarmasin; and three
DENV-2 inAmbon (Table 2). Except DENV, no other flaviviruses
were detected.
The pan-alphavirus RT-PCR only detected one positive
sample. DNA sequencing was performed on the PCR amplicon,
and the resulting sequence was matched with the chikungunya
virus genome. The chikungunya patient was a 3-year-old female
from Ambon. She was admitted to the hospital at day 2 of
fever and reported to experience symptoms of fever, headache,
retro-orbital pain, myalgia, arthralgia, nausea, loss of appetite,
rash, mucosa bleeding, anxiousness, drowsiness, and allergy.
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Dengue virus (DENV) antigen and RNA detection, N (%)
NS1-positive, RT-PCR-negative 6 (1.9) 30 (14.3) 6 (5.6) 42 (5.7)
NS1-negative, RT-PCR-positive 37 (11.7) 32 (10.3) 19 (17.8) 88 (12.0)
NS1- and RT-PCR-positive 63 (20.0) 70 (22.6) 8 (7.5) 141 (19.3)
Virologically confirmed dengue 106 (33.7) 132 (42.6) 33 (30.8) 271 (37.0)
DENV serotype distribution, N (%)
DENV-1 34 (34) 23 (22.6) 20 (74.1) 77 (33.6)
DENV-2 33 (33) 9 (8.8) 5 (18.5) 47 (20.5)
DENV-3 9 (9) 56 (54.9) 0 (0.0) 65 (28.4)
DENV-4 24 (24) 9 (8.8) 1 (3.7) 34 (14.9)
Mixed serotypes 0 (0) 5 (4.9) 1 (3.7) 6 (2.6)
DENV serological diagnosis, N (%)
IgM-positive, IgG-negative 21 (6.7) 31 (10.3) 2 (1.9) 55 (7.5)
IgG-positive, IgM-negative 10 (3.2) 28 (9.0) 12 (11.2) 50 (6.8)
IgM- and IgG-positive 17 (5.4) 153 (49.4) 17 (15.9) 187 (25.5)
Probable dengue 17 (5.4) 116 (37.4) 19 (17.8) 152 (20.7)
Non-dengue patients (all negative) 191 (60.6) 48 (15.5) 55 (51.4) 294 (40.2)
Other arboviruses detection of dengue-NS1- and RT-PCR-negative samples (N = 461)
Pan-flavivirus (dengue) RT-PCR-positive 8 9 3 20
Pan-flavivirus (non-dengue) RT-PCR-positive 0 0 0 0
Pan-alphavirus RT-PCR-positive 0 0 1 1
Bold indicates the significant p-values.
She was provisionally diagnosed as dengue. However, her basic
hematology results were normal, with hematocrit at 39.2%,
platelet count of 198,000/µl, and leukocyte counts of 8,400/µl.
Dengue NS1 rapid-test and DENV RT-PCR detection were
negative. Dengue IgM RDT was negative, while the IgG RDT
was positive.
Characteristics of Virologically Confirmed
Dengue Patients
Dengue-confirmed patients in Ambon were significantly more
likely to be younger (median 5 y.o., range 1–52 y.o.) compared
to those in Banjarmasin (median 16 y.o., range 1–51 y.o.) and
Batam (median 17 y.o., range 1–58 y.o.) (p < 0.001). A higher
percentage of dengue cases in Banjarmasin had positive IgG
results using rapid-tests (72.6%) compared to dengue cases in
Ambon (55.8%) and Batam (22.0%), implying that Banjarmasin
may have more secondary cases compared to the other two cities.
A large proportion of dengue cases in Batam manifested as the
less severe DF (84.9%), while in Banjarmasin, there was an almost
equal proportion of DF and DHF cases, and in Ambon, there
were more DHF (60.6%) cases compared to DF cases (Table 3).
DHF cases were more likely to have thrombocytopenia,
elevated hematocrit, and leucopenia, but this was only statistically
significant for platelet counts and hematocrit (Table 4). There
were no DSS cases or deaths in our study.
The logistic regression analyses on covariates potentially
affecting the symptom variables showed that age and gender did
not add significantly to themodel. In terms of the different DENV
serotypes, there was no significant correlation observed between
the reported symptoms and any particular serotype (Table 5).
Dengue Diagnosis Agreement Among
Study Sites
To compare the diagnostic performance and capability of each
study site in diagnosing dengue among all cases, we assessed
the agreement between NS1 RDT and RT-PCR data. Combining
all data from three study sites, we observed that the overall
sensitivity and specificity of the NS1 RDT were 61.6 and
91.6%, respectively. There was no significant difference in overall
sensitivity and specificity of NS1-tests alone between fever onset
of less and over 3 days. However, combining the NS1 with IgM
results significantly improved overall sensitivity from 61.6 to
78.2% (p < 0.001), but significantly lowered the specificity from
91.6 to 68.7% (p < 0.001).
Differences in diagnostic performance parameters were
observed between the three cities. Rapid diagnostic-test
performed in samples collected in Ambon had significantly
lower sensitivity compared to those in Batam and Banjarmasin.
In contrast, samples collected in Batam had significantly higher
specificity compared to those in Banjarmasin and Ambon. The
trend of increased sensitivity and lowered specificity when NS1
was combined with IgM was also observed when samples were
stratified into the city groups, although statistical significance
was only observed in Banjarmasin (Table 6).
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Dengue fever (DF) 90 (84.9) 67 (50.8) 13 (39.4) <0.001a,c
Dengue hemorrhagic fever (DHF) 16 (15.1) 65 (49.2) 20 (60.6)
Hematology features, median (range)
Platelet (×103/µl) 118.5 (75.8–160.8) 51.5 (34.5–80.0) 77 (43.0–145.0) <0.001b,d
Hematocrit (%) 40.1 (36.6–43.2) 41.3 (38.85–44.45) 36.8 (32.5–41.5) <0.001b,e
WBC (×103/µl) 3.3 (2.5–4.6) 3.1 (2.4–4.5) 5.9 (3.7–10.2) <0.001b,f
aPearson’s chi square-test.
bKruskal–Wallis-test.
cPost-hoc Bonferroni: p < 0.001 (Batam–others), p < 0.001 (Banjarmasin–others), p = 0.017001 (Ambon–others).
dPost-hoc Dunn-test: p < 0.001 (Ambon–Banjarmasin), p = 0.0301 (Ambon–Batam), p = 0.0268 (Banjarmasin–Batam).
ePost-hoc Dunn-test: p < 0.001 (Ambon–Banjarmasin), p < 0.001 (Ambon–Batam), p < 0.001 (Banjarmasin–Batam).
fPost-hoc Dunn-test: p < 0.001 (Ambon–Banjarmasin), p < 0.001 (Ambon–Batam), p < 0.001 (Banjarmasin–Batam).
Bold indicates the significant p-values.
TABLE 4 | Hematology features of virologically confirmed dengue (N = 271)
cases in Batam, Banjarmasin, and Ambon by severity.
Median (range) Severity p-value
DF DHF
Platelet (×103/µl) 100.5 (75.3–149.5) 33.0 (18.0–45.0) <0.001
Hematocrit (%) 39.9 (36.5–42.7) 42.3 (38.6–45.5) 0.008
WBC (×103/µl) 3.3 (2.4–4.7) 3.4 (2.7–4.9) 0.670
Bold indicates the significant p-values.
TABLE 5 | DENV clinical symptoms and serotype relationships.









Headache 51 34 44 22 0.906
Retro-orbital Pain 25 10 15 6 0.645
Myalgia 32 15 31 10 0.879
Arthralgia 18 10 20 5 0.645
Nausea 47 26 47 11 0.291
Loss of appetite 58 29 54 19 0.731
Rash 23 14 27 4 0.164
Bleeding 14 5 24 2 0.568
Enlarged liver 2 2 1 0 0.992
Fluid accumulation 5 2 1 0 0.967
Stomachache 36 17 33 7 0.546
Malaise 55 34 51 16 0.190
Anxiousness 24 11 11 8 0.705
Drowsiness 28 16 18 6 0.495
Allergy 2 5 2 0 0.220
*Binomial logistic regression analysis.
The sensitivity of the NS1 antigen rapid-test was also
significantly different between serotypes, with DENV-1 cases
having a significantly lower sensitivity (42.9%, p < 0.001)
compared to other serotypes, and DENV-2 cases having
significantly higher sensitivity (89.4%, p < 0.001) compared to
other serotypes (Table 7).
DISCUSSION
This study reports the demographic, clinical, virological,
serology, and diagnostic features of dengue and other arboviral
infection in three cities representing three different regions in
Indonesia. The vast geographical area of Indonesia warrants
a comprehensive study to understand the epidemiology of
dengue and other arboviral diseases, which was conducted in
parallel to provide a comprehensive dengue epidemiology data
in Indonesia.
Temporal data indicated that the peak number of dengue-
like illness cases in our study coincided with months of heavy
rainfall in the areas (Figure 2). This is generally in accordance
with dengue seasonal patterns in Indonesia, in which epidemics
are usually associated with increased rainfall (20). Of note is the
dengue peak season in Ambon, which occurred during June–
November, different from the common dengue peak seasons
reported in Indonesia, which tends to occur during the first 6
months of the year (21, 22). However, dengue incidence was
observed to peak in Ambon following the local annual rainy
season. Nevertheless, to our knowledge, our data is the first
to report the temporal difference of dengue peak seasons in
Indonesia, particularly in the eastern region.
Among dengue-like illness patients recruited in this study,
37.0% were virologically confirmed for dengue, and 20.7% were
probable dengue. Altogether, the data showed that the burden
of dengue in Indonesia is still high. Also noted is that different
cities show different proportions of dengue disease, which may
be caused by the diverse climatic and demographic conditions
including herd immunity. We noticed that a relatively low
number of dengue patients were admitted to the hospital in
Ambon compared to those in Batam and Banjarmasin. This is
only to be expected since Ambon (Maluku province) is one of the
provinces with low dengue IR (7).
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TABLE 6 | Sensitivity and specificity of dengue rapid diagnostic tests in clinical setting.























p-value of NS1 only vs.
combined NS1 and/or IgM
0.3154 <0.001 0.2642























p-value of NS1 only vs.
combined NS1 and/or IgM
0.049 <0.001 0.09426
aPost-hoc sensitivity: p = 1 (Batam–others), p = 0.20157 (Banjarmasin–others), p = 0.0018618 (Ambon–others).
bPost-hoc specificity: p < 0.001 (Batam–others), p < 0.001 (Banjarmasin–others), p = 1 (Ambon–others).
cPost-hoc sensitivity: p < 0.001 (Batam–others), p < 0.001 (Banjarmasin–others), p = 0.20502 (Ambon–others).
dPost-hoc specificity: p < 0.001 (Batam–others), p < 0.001 (Banjarmasin–others), p = 0.011796 (Ambon–others).
ePost-hoc sensitivity: p = 0.7071 (Batam–others), p < 0.001 (Banjarmasin–others), p < 0.001 (Ambon–others).
fPost-hoc specificity: p < 0.001 (Batam–others), p < 0.001 (Banjarmasin–others), p = 0.016554 (Ambon–others).
Bold indicates the significant p-values.
TABLE 7 | Performance of DENV NS1 antigen RDT against four different
serotypes of DENV.
Serotype Sensitivity (95% CI) p-value
DENV-1 (N = 77) 42.9 (31.81–54.63) <0.001a
DENV-2 (N = 47) 89.4 (76.11–96.02)
DENV-3 (N = 65) 70.8 (58.00–81.06)
DENV-4 (N = 34) 47.1 (30.16–64.60)
aPost-hoc Bonferroni result: p < 0.001 (DENV-1 vs. others), p < 0.001 (DENV-2 vs.
others), p = 0.091 (DENV-3 vs. others), p = 0.095 (DENV-4 vs. others).
Bold indicates the significant p-values.
In all three study sites, the majority of confirmed dengue
cases occurred in children and adolescents under the age of 20
years, similar to previous studies conducted in Southeast Asia
(23) as well as other areas in Indonesia such as Palembang
(24), Semarang (25), and Jayapura (26), which are located in the
western, central, and eastern regions of the country, respectively.
In general, demographic characteristics such as age and gender
of the patients did not significantly contribute to the presence
or absence of symptoms. However, certain symptoms were
found to have a significant geographical variation, which is not
associated with the different DENV positivity rates between
cities. This may be related to the differences in reporting
styles between different health facilities, which may be due to
cultural differences of how patients in different cities report
their symptoms, or differences in diligence of staff in different
hospitals in recording patient symptoms. The lower Public
Health Development Index in Eastern regions of Indonesia (15)
may be associated with healthcare systems with less experience
and facilities, which may cause more severe dengue cases in
Ambon. Furthermore, although DENV serotypes have been
associated with clinical symptoms (13, 27), we did not observe
a significant relationship between infecting DENV serotype and
clinical symptoms.
Compared to Ambon and Batam, dengue cases in
Banjarmasin were more likely to be secondary infections
and showed more severe manifestations in terms of hematology
data and reported symptoms, including bleeding manifestations.
This is in line with previous studies that observed that secondary
dengue infections lead to more severe disease than primary
infections through antibody-dependent enhancement (ADE)
mechanisms (28, 29). The possibility of higher proportion of
secondary infection in Banjarmasin may be attributed to the
dengue outbreak in the city in the preceding year, i.e., in 2015, in
which dengue IR in the province was ranked 5th in Indonesia,
a drastic increase from 25th in 2014 (30), with IR increasing
further in 2016 (7). Differences in immunologic status reflect the
diversity in dengue herd immunity across Indonesia. Previous
model-based studies showed that the herd immunity threshold
required to block viral transmission is∼50–85% (31, 32), leading
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to the possibility of future outbreaks in areas with low dengue
herd immunity.
The dynamics of dengue epidemiology in the three study
sites was also evident in terms of DENV serotype distribution.
Although all four serotypes were circulating, the predominance
of DENV serotype was different between cities. Almost equal
proportion of DENV-1 and DENV-2 were predominant in
Batam, while DENV-3 was the most prevalent serotype in
Banjarmasin, and DENV-1 in Ambon. This data shows
that the distribution of DENV serotype in Indonesia could
not be generalized across the whole country at any given
period. Spatiotemporal dynamics of serotype distribution is
also supported by previous studies (9, 22). The DENV-3
predominance in Banjarmasin is similar to nearby cities, namely,
Samarinda and Balikpapan, South Kalimantan in 2015–2016
(33). The DENV-1 predominance in Ambon is of particular
interest, especially whether this serotype is directly related with
the low dengue cases in the city. Viral genetic analysis is currently
underway to fully understand the molecular evolution and the
genetic diversity of DENV in the area. Altogether, our study was
the first to report the DENV serotype distributions in Batam,
Banjarmasin, and Ambon.
The differential diagnoses of dengue include other arboviral
diseases (10) such as chikungunya, Japanese encephalitis (JE),
and Zika viruses. In this study we also screened the dengue-
negative samples using pan-flavivirus and pan-alphavirus panels.
West Nile (34) and Zika viruses (4) were previously detected
among sera tested negative for DENV using the same approach.
While ZIKV and JEV have been serologically detected in most
of Indonesian provinces (5, 35), our study failed to detect
other flaviviruses.
Our study shows that pan-flavivirus one-step RT-PCR19 with
95–100% sensitivity developed over 2 decades ago, is still a
good screening assay since it could capture dengue cases tested
negative by the commercial RT-PCR assay used in this study.
This also suggests that although commercial dengue RT-PCR
detection kits are available and widely used, there are possibilities
that not all DENV strains can be detected probably due to
PCR mispriming. High mutational rates of DENV and genetic
diversity have been reported to influence the sensitivity of RT-
PCR (17).
The screening of 461 dengue-negative samples using pan-
alphavirus only detected one chikungunya patient in Ambon.
Chikungunya is reported to be endemic in Indonesia (36), and
with clinical similarity with dengue, misdiagnosis is common
as with the Ambon case. Cocirculation of CHIKV with DENV
has been reported in Indonesia, but at higher rates (37, 38). The
documented circulation of chikungunya in Ambon in the 1970s
to the 1980s (36), with the single chikungunya case detected in
our study may reflect the endemicity of this arbovirus in Ambon.
Rapid-tests for dengue are a fast and convenient method for
diagnosing dengue infections in the clinical setting. Accessibility
and availability of advanced diagnostic procedures are not
distributed evenly across the diverse regions of Indonesia.
We compared the performance of dengue RDT conducted
in the field to the “gold-standard” of real-time RT-PCR. The
overall sensitivity and specificity of the NS1 RDT in our study
samples were 61.6 and 91.6%, respectively, which is comparable
to previously published studies in Asia and South America
(39, 40). In our study, sensitivity for dengue diagnosis was
improved when the NS1 result was read together with IgM,
which is included in the RDT kit and thus convenient to use
concurrently with the NS1-test. This finding is similar to a
study conducted in Sri Lanka, which found improved levels of
sensitivity and specificity when NS1 rapid-test was combined
with IgM (41). However, in our study, we found that while
sensitivity improved with combined results, specificity levels
decreased. These changes in sensitivity and specificity were only
significant for samples with an onset of fever of 3 days and
shorter, which is unexpected since IgM usually rises after 3
days of fever. It may be an underestimation by the patients as
data on days of fever onset in our study was collected through
self-reporting with questionnaires.
In terms of diagnostic sensitivity in detecting DENV
serotypes, we observed that the NS1 RDT used in this
study was less sensitive against DENV-1 (42.9%) and DENV-
4 (47.1%). This highlights the importance of continuous
evaluation and development of DENV NS1 rapid-tests. The
lower sensitivity of NS1 diagnostic against DENV-4 was reported
previously in Indonesia (42, 43), but not for DENV-1, which
is in line with other countries in Asia (39, 44). This is
in contrast with findings from Latin America where the
sensitivity of NS1 rapid-tests was highest in DENV-1 infections
(40). The differences in local DENV genotypes in different
geographic locations may underline the varying sensitivity of
NS1 diagnostics. As observed in our study, Ambon showed
the lowest NS1 sensitivity compared to other cities, most
likely due to a predominance in DENV-1 infection in that
region. Given the diverse clinical, virological, and immunological
conditions across the sites, the differences in dengue RDT
performance when used in different regions in Indonesia should
be anticipated.
While this study provides new information on dengue
epidemiology in Indonesia, limitations exist. Our study did not
assess the entomological aspect of the dengue epidemiology;
therefore, we cannot determine the contribution of vector
control on dengue incidences in the study sites. We also
did not thoroughly analyze weather data such as humidity
and temperature. Nevertheless, we believe that we have shed
some light on the influence of local weather conditions on
dengue incidence.
CONCLUSION
This study reveals that the dengue epidemiology can be dynamic
across the Indonesian archipelago even during the same
period. The diverse geographic, climatic, demographic, and
population characteristics in different regions of Indonesia
most likely contribute to the varied clinical, immunological,
and virological features. Furthermore, the DENV serotype
distribution is distinct between cities and cannot be generalized
for the whole country. This information adds further
understanding of dengue epidemiology in Indonesia and
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may aid in better dengue diagnosis and clinical management in
the country.
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